Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments

By  

Current Medicinal Chemistry, Vol. 22, Iss. 11, 2015-04 ,pp. : 1348-1360

Bentham Science Publishers

Access to resources Recommend Favorite

Pyridine Based Antitumour Compounds Acting at the Colchicine Site

By  

Current Medicinal Chemistry, Vol. 23, Iss. 11, 2016-04 ,pp. : 1100-1130

Bentham Science Publishers

Access to resources Recommend Favorite

3D QSAR studies for the -tubulin binding site of microtubule-stabilizing anticancer agents (MSAAs) - A pseudoreceptor model for taxanes based on the experimental structure of tubulin

By Maccari L.   Manetti F.   Corelli F.   Botta M.  

Il Farmaco, Vol. 58, Iss. 9, 2003-09 ,pp. : 659-668

Elsevier

Access to resources Recommend Favorite

Structural Determinants in the Binding of BB2 Receptor Ligands: In Silico, X-Ray and NMR Studies in PD176252 Analogues

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 14, 2017-04 ,pp. : 1599-1610

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Advantages of Using Synchrotron X-ray Based Techniques in Pediatric Research

By  

Current Medicinal Chemistry, Vol. 20, Iss. 17, 2013-06 ,pp. : 2157-2175

Bentham Science Publishers

Access to resources Recommend Favorite